July 25, 2018

TROGARZO™ INCLUDED IN MOST RECENT TREATMENT GUIDELINES ISSUED BY INTERNATIONAL ANTIVIRAL SOCIETY

Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that TrogarzoTM (ibalizumab-uiyk) injection is now included in the most recent version of the treatment guidelines issued by the International Antiviral Society-USA Panel (“IAS”). The guidelines were published in the latest edition of the Journal of the American Medical Association (“JAMA”).